Replimune Group Inc Stock Price Today (NSE: REPL)

Replimune Group Inc

67.161.52 (2.21%)
Market Closed

Fundamental Score

...

Replimune Group Inc Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Replimune Group Inc share price today is 67.16, down 2.21% on NSE/BSE as of 19 June 2026. Replimune Group Inc (REPL) is a Small-cap company in the Civil Construction sector with a market capitalisation of 233.89 (Cr). The 52-week high for REPL share price is 185.50 and the 52-week low is 60.00. At a P/E ratio of 22.49x, REPL is currently trading above its industry average P/E of 18.93x. The company has a Return on Equity (ROE) of 9.87% and a debt-to-equity ratio of 0.15.

Replimune Group Inc Share Price Chart — NSE/BSE Historical Performance

No data
High
82.99
Low
67.16
Volume
4.0K
Change
-11.62%

Replimune Group Inc share price chart: -11.62% return over the past month. 52-week high ₹185.50, 52-week low ₹60.00.

Replimune Group Inc — Last 10 Trading Days

DateOpenHighLowCloseVolume
68.9869.3965.3567.1614.84K (Cr)
69.6069.6068.6868.6813.49K (Cr)
74.9974.9972.0272.293.03K (Cr)
74.8074.8071.2371.555.96K (Cr)
77.3477.3470.7072.9110.15K (Cr)
74.2074.5072.1173.703.27K (Cr)
71.4274.4070.7272.935.72K (Cr)
70.2172.9070.2171.422.56K (Cr)
69.2572.1869.2571.343.93K (Cr)
73.3973.3970.0070.09734.00 (Cr)

Replimune Group Inc — Last 12 Months Price History

MonthOpenHighLowCloseChange
69.6069.6065.3567.16-3.51%
82.1782.1768.9572.29-12.02%
64.9091.0064.8981.77+25.99%
85.1587.1860.0061.32-27.99%
111.40111.4085.6187.37-21.57%
118.01124.0087.27112.64-4.55%
127.55141.80115.70116.88-8.37%
142.47145.00124.00127.89-10.23%
148.06154.49138.51141.62-4.35%
161.00169.18141.00149.09-7.40%
173.64182.80155.00161.93-6.74%
180.15184.80168.01171.85-4.61%

Returns & Performance

Poor

Return on Equity (ROE)

9.87%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

14.92%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

21.17%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Replimune Group Inc Valuation Check

Poor

Price to Earnings (P/E)

22.49x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

18.93x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

68.55%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.11%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-76.07%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

6.67%

Revenue growth vs same quarter last year

Poor

Revenue Growth (5-Year CAGR)

6.49%

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

22.99%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

24.08%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.15x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

6.24x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-34.67 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Replimune Group Inc Fundamental Analysis & Valuation Benchmarking

Educational evaluation of REPL across key market metrics for learning purposes.

Positive Indicators

7 factors identified

Strong Operating Margins (21.17%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Excellent EPS Growth (22.99% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (24.08% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Conservative Debt Levels (D/E: 0.15)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (6.24x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Balanced Promoter Holding (68.55%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

5 factors identified

Below-Average Return on Equity (9.87%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Profit Decline Concern (-76.07%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Negative Free Cash Flow (₹-34.67 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Limited Institutional Interest (FII+DII: 0.11%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Replimune Group Inc vs Civil Construction Peers

Peer Comparison - Civil Construction

Compare Replimune Group Inc with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
43.6/100
67
₹233.89
22.5
Average
9.87%
Poor
14.92%
Average
0.1
Excellent
24.08%
Excellent
6.49%
Good
0.00%
35.9/100
4048
₹560453.09
34.9
Average
16.55%
Good
14.49%
Average
1.3
Average
9.73%
Good
11.95%
Good
0.83%
34.9/100
252
₹67085.37
59.1
Average
14.01%
Average
14.72%
Average
0.5
Good
11.11%
Good
6.52%
Good
0.53%
60.3/100
99
₹31859.97
47.7
Average
25.54%
Excellent
33.17%
Excellent
0.0
Excellent
51.02%
Excellent
8.28%
Good
0.57%
24.4/100
22
₹26046.27
29.8
Average
5.91%
Poor
7.82%
Poor
1.0
Average
7.82%
Good
2.13%
Average
0.70%
29.9/100
1274
₹20171.65
24.6
Average
9.96%
Poor
15.95%
Good
0.7
Good
8.45%
Good
11.98%
Good
0.76%
48.5/100
503
₹18483.64
27.1
Average
12.02%
Average
17.98%
Good
0.9
Good
0.06%
Average
12.80%
Good
0.79%
14.1/100
318
₹15033.09
29.9
Average
11.06%
Average
19.59%
Good
0.7
Good
14.18%
Good
4.78%
Average
0.61%
30.2/100
140
₹14995.61
25.0
Average
11.33%
Average
11.60%
Average
0.8
Good
8.27%
Good
14.82%
Good
1.66%
60.7/100
993
₹14797.54
33.2
Average
21.78%
Excellent
27.64%
Excellent
0.5
Excellent
37.51%
Excellent
26.03%
Excellent
0.23%
66.3/100
1073
₹13872.92
31.1
Average
12.81%
Average
16.54%
Good
0.0
Excellent
18.85%
Excellent
21.09%
Excellent
0.75%

Replimune Group Inc PE Ratio History

Historical price-to-earnings ratio for REPL — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20217.73₹230.4029.8x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Replimune Group Inc Dividend History

Annual cash dividends paid by REPL — dividend yield N/A

Financial YearDividends Paid (₹ Cr)
FY 20220.69 Cr
FY 20210.43 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Replimune Group Inc Quarterly Performance

Latest quarterly metrics for REPL — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

6.67%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-76.07%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

6.49%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

24.08%

Compounded annual net profit growth over 5 years

Replimune Group Inc Technical Indicators

SMA 50, SMA 200, RSI and volume signals for REPL — calculated from daily price history

26RSI 14
Oversold — RSI 26

Selling pressure is heavy — potential reversal zone.

SMA 50
76
▼ Price below SMA 50 — Short-term bearish
SMA 200
115
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
6K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Replimune Group Inc Financial Statements

Annual income statement, balance sheet and cash flow for Replimune Group Inc (REPL) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Replimune Group Inc

About REPL (Replimune Group Inc)

Replimune Group Inc is reimagining civil construction through its innovative bio-construction approach, seamlessly integrating engineered living materials with traditional infrastr...ucture development. By harnessing the natural capabilities of microorganisms and plant life, Replimune crafts self-healing concrete, bio-receptive facades, and soil-stabilizing solutions. These biomaterials not only reduce the carbon footprint associated with conventional construction methods but also offer enhanced durability and adaptability to changing environmental conditions. Focusing on sustainable and resilient infrastructure, Replimune aims to revolutionize how we build and interact with our urban landscapes, promoting ecological harmony and long-term cost-effectiveness. The company's expertise extends across various sectors, including transportation, water management, and landscape architecture. Replimune provides comprehensive bio-construction services, encompassing material design and development, structural analysis, and on-site implementation. Their team of bio-engineers, architects, and construction specialists collaborate closely with clients to develop customized solutions that address specific project needs and environmental concerns. By incorporating living systems into the built environment, Replimune aims to create infrastructure that not only performs optimally but also actively contributes to ecological restoration and improved air quality. Replimune's commitment to sustainable innovation extends beyond material science to embrace collaborative partnerships with local communities and research institutions. Through these collaborations, the company seeks to advance the understanding and application of bio-construction principles, fostering a more sustainable and resilient future for the civil construction industry. By integrating cutting-edge research with practical application, Replimune is paving the way for a new era of infrastructure development that prioritizes environmental stewardship and long-term societal benefits. Their holistic approach aims to transform cities into living ecosystems that thrive in harmony with nature.

Company Details

Symbol:REPL
Industry:Civil Construction
Sector:Civil Construction

Key Leadership

Mr. Pradeep Misra
Chairman & MD
Mr. Manoj Kumar
Chief Financial Officer
Mr. Rahas Bihari Panda
Company Secretary & Compliance Officer

REPL Share Price: Frequently Asked Questions

What is the current share price of Replimune Group Inc?

Replimune Group Inc (REPL) trades at ₹67.16 on NSE. Market cap ₹233.89 (Cr). Educational data only.

What is the P/E ratio of Replimune Group Inc?

Replimune Group Inc has a P/E of 22.49x vs industry average 18.93x.

What is the Bull Run score for Replimune Group Inc?

Replimune Group Inc has a Bull Run score of 43.6/100 based on 25+ financial parameters.

Does Replimune Group Inc pay dividends?

Replimune Group Inc has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Replimune Group Inc?

Replimune Group Inc has ROE of 9.87%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Replimune Group Inc?

Replimune Group Inc has debt-to-equity of 0.15.

Is Replimune Group Inc a good investment?

Bull Run gives Replimune Group Inc a score of 43.6/100. This is not investment advice — consult a SEBI-registered advisor.